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The characterization of VDJH rearrangements as well as related processes such as somatic hypermutation (SHM) and class switch recombination (CSR) may help to shed light on this area because the differentiation process follows a strict hierarchical order in generating the Ig repertoire. Therefore, studies could indicate the B-cell differentiation stage at which the oncogenic event occurs. Early in B-cell development, rearrangement starts with DH joining to JH. This can produce a complete functional VDJH rearrangement but can also remain as an incomplete non-functional rearrangement that forces the second allele to be rearranged. Incomplete rearrangements are frequently found in precursor B-cell acute lymphoblastic leukemia, 3 but may also occur in mature B-cell lymphoproliferative disorders, such as multiple myeloma, 4 and hairy cell leukemia. 5 It is unknown whether incomplete DJH rearrangements exist in WM. Incomplete DJH rearrangements may be an interesting alternative target for polymerase chain reaction (PCR)-based clonality assessment because they lack SHM. Finally, in contrast to other Bcell lymphoproliferative disorders, [6] [7] [8] [9] in WM information on the composition of the third complementary determining region (CDR3) and frequency of SHM is limited.
The normal counterpart of the WM malignant cell is believed to be a post germinal center IgM B cell that transforms once somatic mutation has ended. Traditionally, it has been assumed that WM cells are constitutively unable to or are being prevented from carrying out isotype CSR. 10, 11 It was initially suggested that this was due to the presence of genetic abnormalities involving the CSR machinery, but this possibility has been excluded since the machinery seems to be intact. 12 Another explanation could be the absence of mutations at the switch region. 12 Despite this presumed lack of CSR, ex-vivo clonotypic transcripts encoding postswitch isotypes have recently been detected in WM and IgM-MGUS cells cultured with CD40L/interleukin-4. 12 This would indicate that CSR is possible in WM cells, but up until now, this has not been shown to occur in vivo. In this study, we characterized complete VDJH and incomplete DJH rearrangements in 64 patients with untreated WM and eight with IgM-MGUS, and documented the existence of CSR in 29 of them.
Design and Methods

Patients and diagnosis
Seventy-two patients with monoclonal IgM disorders were included in the study. According to the consensus criteria from the 2 nd International Workshop of WM, 1 64 of them had a diagnosis of WM and eight were considered to have an IgM-MGUS. Although the existence of bone marrow infiltration by lymphoplasmacytic lymphoma was established by bone marrow biopsy, the presence of tumor B cells was always confirmed by immunophenotypic analysis with flow cytometry, including evaluation of surface and cytoplasmic IgM expression.
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Genomic DNA preparation, mRNA extraction and cDNA synthesis High molecular weight DNA was isolated from bone marrow samples from all patients according to standard methods. 4 In addition, total RNA was isolated from samples with representative tumor cells from 21 WM patients as well as in all the eight IgM-MGUS patients, using the guanidium thiocyanate/phenol chloroform method. Reverse transcription was performed on 1 µg of total RNA, according to the rules and protocols approved in the Europe Against Cancer Program (EAC).
14
PCR amplification of the VDJH, DJH and VDJ-C of rearranged IgH genes
For amplification of complete VDJH rearrangements, a set of family-specific primers of the framework 1 (FR1) region and one JH consensus primer were used in a multiplexed PCR reaction. When no amplification was detected from FR1, PCR was carried out from FR3, in which case analysis of SHM was impossible. Amplification of incomplete DJH rearrangements was performed in two different reactions using family-specific primers for DH1 to DH6 and DH7 families, respectively, together with the consensus JH primer. All primers were designed and tested during the BIOMED-2 Concerted Action: PCR based clonality studies for early diagnosis of lymphoproliferative disorders (BMH4-CT98-3936), in which our group participated actively in standardization. 15 All reactions were carried out in a 50 µL mixture containing 0.1 µg DNA and 10 pmoL of each primer. All these amplifications were carried out using genomic DNA. 15 Pre-and post-switch clonal isotype expression was analyzed from RNA using a slight modification of the method described by Billadeau et al. 16 First-round cDNA amplification was carried out in 50 µL reactions using the family-specific VH primer as the forward primer and the constant region primer as the reverse primer. The second-round amplification was carried out in 50 µL reactions with 5 µL of the first-round amplification product, family-specific VH primers and an internal constant region primer. Amplified products were denatured for 5 min at 95ºC and renatured for 60 min at 4ºC to allow heteroduplex and/or homoduplex formation. The final product was then electrophoresed on an 8% polyacrylamide gel and visualized under UV light after ethidium bromide staining.
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Sequencing and analysis of IgH genes
Monoclonal PCR products were purified from polyacrylamide gels for direct sequencing in an automated ABI 377 DNA sequencer using BigDye ® Terminator with the v1.1 Cycle Sequencing kit (Applied Biosystems).
Germline VH, DH and JH segments from complete VDJH rearrangements were identified by comparison with the V BASE. 17 An IgH diversity gene segment (DH) was identified in most cases (DH1, DH4, DH5, DH6 and DH7) by homology of a minimum of six successive nucleotides (nt) or seven successive nt interrupted by no more than two mismatches with the germline sequence. 18 In the remaining cases, involving the longest DH families (DH2 and DH3), the DH gene was identified using a stricter criterion: at least ten consecutive nt. 19 The ability to code for functional Ig heavy chains was determined by translating VDJH DNA sequences into amino acids.
DH and JH germline segments from incomplete DJH rearrangements were identified using the BLAST search (accession number X97051).
In the same way, all PCR products obtained by RT-PCR with VH family-specific primers and CH-specific primers (CSR amplifications) were also sequenced and compared with the original VDJH clonotypic sequence as well as with the BLAST sequences.
The VH, DH and JH distribution obtained in functional VDJH rearrangements was compared with that occurring randomly in normal B-cell populations, 17, 18, 20 as well as with that observed in DJH, non-functional rearrangements.
Composition of the third complementary-determining region
The length of the CDR3 was determined by counting the number of amino acids between the last amino acid of FR3 and the first amino acid of the JH (FR4). 21 To detect whether a particular antigen might have been responsible for the antigen-selective pressure observed in those cases showing features of antigen selection, we evaluated nucleotide and derived amino acid sequence similarities of the CDR3 regions.
Somatic hypermutation
To confirm base changes in the germline IgH sequence, two independent PCR amplifications for each sample were sequenced in both the forward and reverse amplified fragment in order to observe the same change in separate reactions. VH sequences containing ≥2% deviation from the germline sequence were considered to be somatically mutated. 22 The nucleotide sequences were translated to amino acids in order to determine whether a mutation was a replacement (R) or silent (S). In such cases, the binomial algorithm described by Chang and Casali 23 was used to discriminate between R and S mutations in CDR and FR derived from antigen selection or acquired randomly. This analysis is based on the fact that as a result of antigen-selective pressure, the R/S ratio of amino acid mutations is higher than expected in the CDR regions, which is consistent with the need to provide the best fit for the antigen. In contrast, the R/S ratio is lower in the FR regions in order to conserve the antibody structure. p values ≤0.05 according to the binomial distribution model were considered statistically significant indicators of antigen-selective pressure. We also analyzed mutations in DH and JH regions, considering that these regions were mutated when they contained one or more mutations.
Results
Detection of monoclonal rearrangements by PCR
All patients (100%) showed monoclonal rearrangement when complete functional VDJH and/or incomplete non-productive DJH were amplified. VDJH rearrangements were detected in 58 out of 64 WM patients (91%) and in all eight Ig-MGUS patients (100%). DJH rearrangements were observed in 27 of the 64 WM patients (42%) and in one of the eight patients with IgM-MGUS (13%).
VDJH rearrangements: VH, DH and JH gene segment usage
VH, DH and JH gene segment usage, as well as the rate of SHM for all WM and IgM-MGUS patients are shown in Table 1 . Table 2 shows the expected and observed frequencies of VH gene segments per family. Patients with WM displayed an under-representation of the VH1 family (4/58; 7%) and a marked over-representation of the VH3 family (44/58; 76%). In addition, the VH3-23 gene segment was very highly used, since it was present in 17 out of the 58 identified functional rearrangements (29%), a frequency much higher than would be expected from random occurrence (1.96%; p<0.001). In contrast, several VH segments frequently found in normal early and/or 
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circulating B cells, such us VH3-20 and VH3-49, which were completely absent in this series (Table 1) . DH segments could be identified in only 22 of the 58 VDJH rearrangements detected (38%), according to stringent criteria. 18, 19 The most frequently involved families were DH1 and DH6, each present in six of 22 cases (27%), while the least frequent was DH2 (4.5%) (Table  3) . Finally, the most commonly represented JH families were JH4 (16/45; 35%) and JH6 (11/45; 24%) ( Table 4 ). The distribution of both DH and JH families in WM did not differ significantly from the distribution in normal B lymphocytes.
IgM monoclonal gammopathy of undetermined significance
Only the VH3 and VH4 families were represented within complete VDJH rearrangements in patients with IgM-MGUS (6/8 and 2/8, respectively) ( Table 2 ). The DH element was identified in five cases, and DH1 was the most represented family (3/5; 60%) ( Table 3 ). The JH selection was not specifically different from the pattern observed in other B-cell malignances or normal B cells.
CDR3 analysis
The CDR3 sequence could be analyzed in detail in 45 WM patients. The average lenght was 26.6 nt±10.7nt. As mentioned above, the DH element was identified in 22 patients (49%), in whom the average length of the CDR3 region was 30 nt±11.4. The remaining 23 cases contained an unidentifiable DH element according to conventional criteria, 18, 19 probably because the CDR3 length was shorter (23 nt±9.12) ( Table 1) . No consensus sequence showing evidence of selection by the same antigen could be demonstrated between the CDR3 regions of the rearranged Ig genes.
The CDR3 was analyzed in seven of the eight cases of IgM-MGUS and had a mean length of 24 nt±11.4. In the five cases in which the DH segment was identified, the mean length of 28.8 nt±7.5 was longer than in the two cases without an identified DH segment in whom the mean length was 13.5 nt±14.8.
DJH rearrangements: DH and JH family usage
DJH rearrangements were detected in 27 WM cases (42%), with a preferential usage of the DH2 family (13/27; 48%) ( Table 3 ). In almost half of these rearrangements, only two segments were selected (DH2-02 in eight cases and DH4-23 in five) ( Table 2) . Regarding JH segments, only JH4, JH5 and JH6 were selected in these rearrangements (Table 4) . Finally, incomplete rearrangements were detected in only one IgM-MGUS patient (13%) in whom DH4 and JH3 gene segments were used (Table 1) .
Somatic mutation analysis
The complete sequence was available for somatic mutation analysis for 52 of the 58 patients with WM and seven out of the eight with IgM-MGUS. The 
remaining cases could only be amplified from FR3, which prevents such analysis. Using the 2% deviation from the germline sequence as a cut-off value for SHM, 90% of WM and 71% of IgM-MGUS cases had SHM. Within these cases, the mean deviation from the germline was 8.7% (range 4.3-16.2) in WM and 7.1% (range 4.4-10.6) in IgM-MGUS. This means that there were seven cases lacking SHM (five WM and two IgM-MGUS). Interestingly, three of them (two WM, one MGUS) had a complete match with the germline configuration (0% deviation). The JH segment contained occasional mutations in 71% of the VDJH rearrangements. The SHM pattern was investigated to ascertain whether WM and IgM-MGUS cases had different features concerning random or antigen-driven selection. The distribution of R and S mutations in the FR and CDR regions is summarized in Table 1 . A random distribution of SHM was observed in 23% of WM patients and in 60% in IgM-MGUS patients.
The vast majority of the incomplete DJH rearrangements were unmutated, since we observed only occasional single point mutations in three cases.
Class switch recombination
Twenty-one WM patients and eight IgM-MGUS patients had representative mRNA available to test the presence of pre-switch (IgM, IgD) and post-switch (IgA, IgG) isotype expression. As expected, IgM clonotypic transcript isotypes were present in all samples and IgD in most of them (83%), with exactly the same clonotypic sequence as that obtained from genomic DNA. Interestingly, hemi-nested RT-PCR revealed the presence of post-switch clonotypic isotypes in three WM patients: two IgA and one IgG. In these three cases, sequencing of CSR amplified products showed the same CDR3 (VH-DH-JH) sequence and the same somatic hypermutation pattern, which demonstrates that all isotypes were derived from the same clone.
Discussion
In this study we characterized molecular IgH rearrangements in 72 patients, 64 of whom had WM and eight of whom had IgM-MGUS. This constitutes the largest series of patients with IgM-related disorders studied up to now; indeed, combining previous literature data, only 59 cases have so far been reported. 11, 12, 24, 25 Our results confirm previous estimations about IgH repertoire usage and show that incomplete rearrangements are frequent in WM. In addition, we also confirm that isotype switching is possible in vivo in WM.
Previous studies on mutation analysis of antigen receptor genes revealed that most cases of WM presumably derive from a post-germinal center cell, a cell with somatic hypermutation, but without evidence of CSR. 10, 11 However, the low number of cases previously analyzed made it impossible to ascertain whether there is a bias in VDJH repertoire selection. Our study definitively demonstrated a preferential usage of VH3 family segments, with a >75% representation, which is much higher than that observed in normal B cells 17 or in other lymphoproliferative disorders such as multiple myeloma, 26 hairy cell leukemia 5 or chronic lymphocytic leukemia. 19 These results concur with those previously reported by Kriangkum et al., 10, 12 who described a 93% usage in 15 patients, although our study demonstrates that the use of other segments is not an exception. The VH3-23 segment was selected in nearly one-third of all WM cases, which contrasts with the complete absence of this segment in IgM-MGUS cases. Another interesting finding in our series is the usage of the JH segment, which is relatively more diverse than that described by Kriangkum et al., 12 who found that the frequency of usage of JH4 was as high as 73%. Other B-cell lymphoproliferative disorders such as multiple myeloma and Bcell chronic lymphocytic leukemia have also shown, as in our series of WM patients, a diverse JH selection. 19, 26 DJH rearrangements were observed in 42% of WM patients, a frequency similar to that observed in other mature B-cell lymphoproliferative disorders. 4, 5 In contrast, these incomplete rearrangements were less frequent (13%) in IgM-MGUS cases, which suggests some differences in the neoplastic origin of the two entities. The use of DH and JH segments differed between cases with complete and incomplete rearrangements. This could indicate that DH1, DH3 and DH6 family selection (very frequent in complete rearrangements and almost absent in incomplete rearrangements) would favor a functional result, while the use of DH2, and especially the DH2-02 gene segment (never present in complete VDJH functional rearrangements but frequent in incomplete rearrangements), could lead to non-productive rearrangements, similar to pseudo-genes.
The average length of the CDR3 was 26.6 nt, which is shorter than previously reported. 27 This shorter CDR3 is typical of B cells selected for binding to antigens. 28 The CDR3 is the region where the greatest evidence of positive and negative selection was observed, especially for the use of different DH families between complete and incomplete rearrangements. This is in line with the key role that the CDR3 plays in antigen recognition. 28, 29 In the present series, the percentage of cases with somatic hypermutation according to conventional criteria was very high: 90% for WM and 71% for IgM-MGUS. Nevertheless, five out of the 52 WM cases tested (9.6%) showed a naïve B-cell origin, which concurs with other published data. [10] [11] [12] 24, 30 This would indicate that the transformation event that leads to WM or IgM-MGUS does not necessarily target somatically mutated B cells.
Antigenic selection was detected in 77% of the cases of WM, a figure more than twice that previously reported. 10, 12, 31 This difference could be due to variations in ref-
erence databases, 32 but some differences could also be caused by the multimodal 33 or binomial 23 models used in the analyses. Interestingly, antigenic selection was found in only 40% of cases of IgM-MGUS, again suggesting some possible differences between WM and IgM-MGUS.
Considering all these data together, we can hypothesize that WM and IgM MGUS may develop differently, at least in a subgroup of IgM MGUS patients whose disease will never evolve into WM. This hypothesis is compatible with the results of mutational analysis of the upstream Sµ region recently published by another group. 12 Therefore, molecular analysis could be an interesting tool for a better diagnostic definition of IgM MGUS, identifying patients at a high risk of malignant evolution. However, it must be appreciated that this hypothesis is based on a very small group of IgM MGUS patients (four in Kriangkum's study and eight in the present one), so additional studies are required to confirm this possibility.
Although several studies found only clonotypic IgM transcripts in WM patients, 10 ,11,34 a recent study demonstrated that WM cells are capable of undergoing CSR in vitro. 12 In the present series, we found and sequenced post-switch clonotypic isotypes in three out of 21 cases with representative RNA available, demonstrating that WM cells are capable of undergoing CSR in vivo, albeit rarely. Furthermore, we recently reported a case showing that not only are WM cells capable of undergoing CSR in vivo, but that the CSR can be functional, since an additional IgG serum M-component was observed five years after diagnosis. 35 Therefore, the fact that WM cells do not usually carry out CSR can no longer be explained by the presence of irreversible genetic lesions, but is more probably due to a response to inhibitory regulation. Accordingly, such negative regulation could eventually be overcome depending on the microenvironmental conditions, as occured in three of our cases.
In conclusion, in this study we characterized IgH rearrangements in the most extensive series of IgMrelated disorders reported up until now. We have documented some dissimilarities in VDJH and DJH rearrangements between WM and IgM-MGUS, which could suggest a distinct differentiation process between the two disorders. In addition, we found evidence demonstrating that WM cells are capable of undergoing CSR in vivo, which was initially thought to be impossible in this disease. 
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